Abstract
dc:descriptionBACKGROUND AND AIM:To report on the prevalence of inflammatory bowel disease (IBD) related intestinaldysplasia and cancer in northwestern Greece.PATIENTS AND METHODS:Single referral center retrospective study. The policy among all gastroenterologistsof the area regarding medical treatment, patient follow up and bowel surveillancestrategies including risk factors is the same.RESULTS:We analyzed 1494 colonoscopies from 696 consecutive IBD patients (494 UC).The follow up time [median, IQR] was 16 [8-23] years and the age at diagnosiswas 28 [21-49] years. The number of patient years at risk was 16.219. Diseaselocation for UC was: pancolitis 761 (59%), left sided colitis 455 (35%), and proctitis69 (6%). Disease location for CD was: colitis 142 (66%), ileitis 45 (22%) andileocolitis 21 (10%). Disease activity was in remission in 1240 (83%) of them. Intotal, 498 (72%) patients were on mesalazine, 169(24%) on immunosuppressionand 29 (4%) on biologicals. Biopsies were taken randomly in 1429 (96%)endoscopies and were targeted in 65 (4%) of them. We recorded 69 (9.4%) caseswith dysplasia and 10 (1.4%) cases with intestinal cancer (9 in UC). No differencewas found for dysplasia and cancer in patients who followed up for 10-20 years orfor more than 20 years.CONCLUSIONS:The prevalence of dysplasia and cancer is increased in UC compared to CD butthe prevalence of high-grade dysplasia is comparatively low. Intestinal cancerprevalence is increasing after the first decade and then practically remains stable.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zoumpas, Stefanos
- Ζούμπας, Στέφανος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43817